Source:http://linkedlifedata.com/resource/pubmed/id/20155339
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-4-5
|
pubmed:abstractText |
Although great advancements have been witnessed in treatment results for hematopoietic tumors in recent years, development of secondary malignant tumors induced by anti-cancer drugs still remains a serious issue. We experienced a case of secondary myelodysplastic syndrome (MDS), possibly induced by cyclophosphamide (CY), which was spontaneously resolved by discontinuance of CY. A 24-year-old woman was diagnosed with follicular lymphoma in January 1998: she had developed bulky intra-abdominal lymphadenopathy, with repeated relapse and remission by several chemotherapy treatments. Remission was induced by rituximab, administered at the time of relapse in 2001, followed by administration of 50 mg/day of CY since December 2001 for the prevention of relapse. Anemia and thrombocytopenia developed around January 2003. Bone marrow aspiration revealed abnormality in two lineages and a complicated chromosomal anomaly, and the patient was diagnosed with MDS. Discontinuance of CY and administration of an anabolic steroid improved anemia and thrombocytopenia within 2 years. Bone marrow aspiration in 2006 showed improvement in morphological abnormality and disappearance of chromosomal abnormality.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1865-3774
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
530-3
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20155339-Antibodies, Monoclonal,
pubmed-meshheading:20155339-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:20155339-Antineoplastic Agents,
pubmed-meshheading:20155339-Antineoplastic Agents, Alkylating,
pubmed-meshheading:20155339-Cyclophosphamide,
pubmed-meshheading:20155339-Female,
pubmed-meshheading:20155339-Humans,
pubmed-meshheading:20155339-Lymphoma, Follicular,
pubmed-meshheading:20155339-Myelodysplastic Syndromes,
pubmed-meshheading:20155339-Remission Induction,
pubmed-meshheading:20155339-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance.
|
pubmed:affiliation |
Division of Medicine, Department of Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi Ward, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|